|
SN-NJ-R138
N/A |
|
Hyaluronic acid nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R139
N/A |
|
Composite hydrogel containing doxorubicin and ectolida nanoparticles
|
¥Member visible
|
|
SN-NJ-R140
N/A |
|
Dexamethasone PEG-PLGA Nanoparticle Composite Hydrogel
|
¥Member visible
|
|
SN-NJ-R141
N/A |
|
Hydroxycamptothecin nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R142
N/A |
|
Folic acid coupled with paclitaxel PEG-PLGA nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R143
N/A |
|
TPGS emulsified nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R144
N/A |
|
Puerarin HA/PEG-PLGA Nanoparticle Composite Hydrogel
|
¥Member visible
|
|
SN-NJ-R145
N/A |
|
Streptavidin-containing nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R146
N/A |
|
Co-loaded siRNA and docetaxel nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R147
N/A |
|
Composite hydrogel containing irinotecan nanoparticles
|
¥Member visible
|
|
SN-NJ-R148
N/A |
|
Indocyanine green and liquid fluorocarbon dual-mode contrast nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R149
N/A |
|
R8 modified nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R150
N/A |
|
Baicalein-loaded PLGA nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R151
N/A |
|
Astaxanthin nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R152
N/A |
|
Phospholipid nanoparticle composite hydrogel with core-shell structure
|
¥Member visible
|
|
SN-NJ-R153
N/A |
|
RGD modified nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R154
N/A |
|
Nanoparticle composite hydrogel loaded with basic fibroblast growth factor
|
¥Member visible
|
|
SN-NJ-R155
N/A |
|
Rifabutin nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R156
N/A |
|
PEI modified PLGA nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R157
N/A |
|
Thymopentapeptide nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R158
N/A |
|
Palifampicin Nanoparticle Composite Hydrogel
|
¥Member visible
|
|
SN-NJ-R159
N/A |
|
Rapamycin nanoparticle composite hydrogel capable of inhibiting vascular smooth muscle cells
|
¥Member visible
|
|
N-NJ-R160
N/A |
|
Coumarin-6 nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R162
N/A |
|
Mannose modified chitosan nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R161
N/A |
|
Matrine loaded nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R162
N/A |
|
Mannose modified chitosan nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R163
N/A |
|
Antifungal itraconazole nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R164
N/A |
|
DNA/RNA/plasmid nanoparticle controlled release hydrogel
|
¥Member visible
|
|
SN-NJ-R165
N/A |
|
Cyclovastatin PLGA nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R166
N/A |
|
Methotrexate-loaded PLGA nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R167
N/A |
|
Gene-carrying cationic PLGA nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R168
N/A |
|
Neurotoxin-loaded PLGA nanoparticle composite hydrogel
|
¥Member visible
|